Efficacy, safety, and cost of new anticancer drugs : Pessimistic conclusion was not justified

Benzer Materyaller

• Data presented do not justify pessimistic conclusions
  Yazar:: WRIGHT, C
  Baskı/Yayın Bilgisi: (2001)
• Efficacy, safety, and cost of new anticancer drugs
  Yazar:: Garattini, Silvio, ve diğerleri
  Baskı/Yayın Bilgisi: (2002)
• Tacrine and lecithin in Alzheimer's disease. Negative conclusions not justified.
  Yazar:: Wilcock, G. K.
  Baskı/Yayın Bilgisi: (1994)
• Drug costs and drug safety.
  Baskı/Yayın Bilgisi: (1967)
• Tuning the metabolism of the anticancer drug cisplatin with chemoprotective agents to improve its safety and efficacy
  Yazar:: Sooriyaarachchi, Melani, ve diğerleri
  Baskı/Yayın Bilgisi: (2016)